Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Mississippi for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Mississippi only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Mississippi (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Elizabeth Herrington (NPI 1306043278)

Field	Value
Entity Type	Individual
Organization	Elizabeth Herrington
Address	1227 N State St Ste 101
City	Jackson
State	MS
ZIP	39202
Taxonomy	Medical Oncology Physician
NPI Enumerated	July 2, 2007

Payer Source	Total Paid
Medicare	$1.9M
Medicaid	$0

Key Findings

ELIZABETH HERRINGTON is listed as a Medical Oncology Physician in JACKSON, MS with an NPI enumerated on 2007-07-02 (~19 years ago). Her billing footprint is concentrated in Medicare with Total Medicare revenue of $1.9M and no Medicaid billing on file (none below), indicating an effectively single‑payer Medicare practice.

Revenue concentration is high: the precomputed top 3 Medicare codes — J9271 (25.5%), J9299 (23.6%), and J1568 (14.2%) — together account for 63.3% of this provider's total Medicare revenue. That level of concentration around three infused/infusible codes suggests a business model dependent on a narrow set of high‑value therapies.

The code mix points to an infusion‑centric oncology/hematology operation: J9271 and J9299 are high‑revenue immuno‑oncology agents (pembrolizumab and nivolumab) and J1568 is a large share of immune globulin infusions. Supporting medications and services — including growth factors (J1449, J2506), bone‑modifying agent J0897, chemotherapy administration (96413, 96365, 96367, 96417), and multiple lab panels — are consistent with ongoing systemic cancer care and routine treatment monitoring.

Competitive standing across top drugs is mixed: J9271 appears at a modest national position (rank #1079 of 1841, 41th percentile; typical, unremarkable volume for this code), J9299 sits at a moderate peer position (rank #193 of 505, 62th percentile; typical, unremarkable volume for this code), while J1568 is relatively strong versus peers (rank #41 of 381, 89th percentile; typical, unremarkable volume for this code). These rankings indicate the provider is not a dominant national center for checkpoint inhibitors overall but shows above‑peer activity for immune globulin infusions.

Several utilization signals stand out as above‑typical: office E/M code 99214 accounts for 997 claims and $85.7K revenue (4.8% of Medicare revenue) and ranks #11529 of 479517 providers (98th percentile; notably above typical national volume), and antiemetic J0185 has 25K claims and $25K revenue and ranks #32 of 819 providers (96th percentile; notably above typical national volume). Together these suggest higher‑than‑average visit volume and frequent supportive care prescribing associated with active systemic therapy.

Operationally, the practice shows large claim counts in low‑reimbursed supply/drug codes and routine labs: for example J1439 has 34.5K claims at $1 avg paid/claim for $34.5K revenue (1.9% of Medicare revenue), while labs such as 80053 (2K claims, $20.3K revenue) and 85025 (2.8K claims, $19.3K revenue) rank in the high percentiles versus peers. This pattern is consistent with frequent monitoring and high throughput of ancillary services that accompany infusion care.

Payer mix and financial exposure are concentrated: with $1.9M in Medicare revenue and no Medicaid billing on file (none below), the provider has minimal Medicaid participation and therefore limited Medicaid revenue diversification. That concentration can simplify billing processes but creates sensitivity to Medicare policy and reimbursement changes for high‑cost infusible agents.

Taken together, the profile indicates a specialized, infusion‑focused oncology practice with most revenue driven by a few high‑value injectable therapies and immune globulin, mixed national competitiveness (typical volumes for major immunotherapies but relatively elevated activity for immune globulin and select supportive codes), and a Medicare‑dominated payer mix that has been in place since the NPI was enumerated on 2007-07-02 (~19 years ago).

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

65 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	10,800	$40	$453.6K
J9299	Injection, nivolumab, 1 mg	18,240	$20	$419.5K
J1568	Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg	7,920	$30	$253.4K
J0897	Injection, denosumab, 1 mg	8,580	$20	$154.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,000	$90	$85.7K
J1449	Injection, eflapegrastim-xnst, 0.1 mg	2,900	$30	$75.5K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	880	$80	$71K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	510	$90	$42.9K
J1439	Injection, ferric carboxymaltose, 1 mg	34,500	$1	$34.5K
J0185	Injection, aprepitant, 1 mg	24,960	$1	$25K

Showing 1–10 of 65

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 65 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Mississippi Distribution

Elizabeth Herrington — 3 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Mississippi

Full comparison — all codes billed, vs. state median

65 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	12	10	16,700	$40	$1M
J9299	5	10	21,120	$20	$569.7K
J1568	2	10	7,420	$30	$393.8K
J1449	8	10	4,160	$30	$149.3K
J0897	26	110	3,030	$20	$95.7K
J2506	6	10	910	$80	$91.5K
J1439	11	20	42,000	$1	$41.6K
J0185	3	10	18,330	$1	$26.4K
96413	13	70	100	$80	$22.6K
99214	230	4,110	170	$70	$21.9K

Showing 1–10 of 65

Related Providers

Other providers that share a Tax Identification Number (TIN) with Elizabeth Herrington, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Singing River Health System	MS	General Acute Care Hospital	$0	$81.1M
Anderson Regional Medical Center	MS	General Acute Care Hospital	$0	$32.5M
Singing River Gulfport	MS	General Acute Care Hospital	$0	$24.9M
Guangzhi Qu	MS	Hematology & Oncology Physician	$9.1M	$0
Anderson Regional Medical Center	MS	Rural Health Clinic/Center	$0	$5.4M
Tammy Young	MS	Medical Oncology Physician	$5.1M	$0
Singing River Health System	MS	Internal Medicine Physician	$0	$4.8M
Singing River Health System	MS	Multi-Specialty Clinic/Center	$0	$4.4M
Anderson Regional Medical Center	MS	General Acute Care Hospital	$0	$4.1M
Justin Baker	MS	Hematology & Oncology Physician	$4.1M	$0

Nearby Providers

Other providers in the same ZIP code as Elizabeth Herrington, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mississippi Behavioral Health Services, LLC	MS	Community/Behavioral Health Agency	$0	$72.8M
Mississippi Baptist Medical Center, Inc.	MS	General Acute Care Hospital	$0	$42M
Mississippi Children's Home Society - Mypac	MS	Mental Illness Community Based Residential Treatment Facility	$0	$26.5M
Medical Foundation Of Central Mississippi, Inc.	MS	Internal Medicine Physician	$0	$7.5M
James Brown	MS	Retina Specialist (Ophthalmology) Physician	$5.4M	$8.9K
Michael Borne	MS	Retina Specialist (Ophthalmology) Physician	$4.5M	$1.8K
Mississippi Physicians, LLP	MS	Emergency Medicine Physician	$0	$4.2M
Mae Physicians Surgery Center, LLC	MS	Ambulatory Surgical Clinic/Center	$3.4M	$114.8K
Chelsea Cockrell	MS	Family Nurse Practitioner	$3M	$0
Mississippi Urology Outpatient Surgery Center, LLC	MS	Ambulatory Surgical Clinic/Center	$1.8M	$9.8K

Elizabeth Herrington — Billing Profile & Reimbursement Data

Sign up for Elizabeth Herrington — Billing Profile & Reimbursement Data policy alerts

Elizabeth Herrington — Billing Profile & Reimbursement Data

Sign up for Elizabeth Herrington — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References